LBRX
LB Pharmaceuticals Inc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Largest filed tie
0
filed ties
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
LB Pharmaceuticals Inc
41.20
Expected move
Inputs8Q avg ±3.0%·×2.94·rich
straddle ±12.5%
spot 39.70exp Nov 20ATM strike 40ATM straddle 5.83IV 76%
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Deep Track CapitalDeep Track Capital | $108.8M | 11.26% | 0.00% | |
| 2 | BlackRockBlackRockindex-like | $88.7M | 9.19% | +10.66% | |
| 3 | RA Capital ManagementRA Capital Management | $71.7M | 7.42% | 0.00% | |
| 4 | Trails Edge Capital PartnersTrails Edge Capital Partners | $49.4M | 5.12% | +15.44% | |
| 5 | JPMorgan ChaseJPMorgan Chase | $48.9M | 5.06% | +4.88% | |
| 6 | Commodore CapitalCommodore Capital | $48.7M | 5.04% | 0.00% | |
| 7 | TCG Crossover ManagementTCG Crossover | $47.0M | 4.86% | −21.32% | |
| 8 | Caligan PartnersCaligan Partners | $46.7M | 4.83% | 0.00% | |
| 9 | Spruce Street CapitalSpruce Street Capital | $44.7M | 4.62% | 0.00% | |
| 10 | Nantahala Capital ManagementNantahala | $34.2M | 3.54% | 0.00% | |
| 11 | Vanguard Capital ManagementVanguardindex-like | $31.5M | 3.26% | +8.55% | |
| 12 | Balyasny Asset ManagementBalyasny | $29.9M | 3.10% | −0.24% | |
| 13 | Alyeska Investment GroupAlyeska Investment | $28.0M | 2.90% | 0.00% | |
| 14 | Vivo CapitalVivo Capital | $26.0M | 2.69% | 0.00% | |
| 15 | Nan Fung Group HoldingsNan Fung | $20.5M | 2.12% | 0.00% | |
| 16 | Geode Capital ManagementGeodeindex-like | $19.9M | 2.06% | +18.25% | |
| 17 | State StreetState Streetindex-like | $19.5M | 2.02% | +19.36% | |
| 18 | Logos Global ManagementLogos Global | $19.0M | 1.97% | −36.07% | |
| 19 | Goldman Sachs GroupGoldman Sachs | $18.7M | 1.94% | +58.45% | |
| 20 | Jennison AssociatesJennison | $17.6M | 1.82% | +0.50% | |
| 21 | Great Point PartnersGreat Point Partners | $10.3M | 1.07% | +5.74% | |
| 22 | Boothbay Fund ManagementBoothbay Fund | $8.9M | 0.93% | new | |
| 23 | Millennium ManagementMillennium | $8.4M | 0.87% | +89.26% | |
| 24 | Ameriprise FinancialAmeriprise Financial | $7.4M | 0.76% | +110.04% | |
| 25 | Citadel AdvisorsCitadel | $7.0M | 0.73% | −48.20% |
114 managers report $966.1M of LB Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 18 of them hold 80% of it; Deep Track Capital is largest at 11.26%.